CD109 is drastically expressed in cervical cancer and upregulates epidermal growth factor receptor (EGFR)-mediated STAT3 phosphorylation, enabling cervical cancer cell migration and proliferation, and supporting cancer cell phenotype [161]. Here, EGFR is linked to cervical carcinoma.